molecules

Review
Beyond the Bark: An Overview of the Chemistry and Biological
Activities of Selected Bark Essential Oils †
Melanie Graf and Iris Stappen *

Department of Pharmaceutical Sciences, University of Vienna, 1090 Vienna, Austria

* Correspondence: iris.stappen@univie.ac.at; Tel.: +43-1-4277-55552
† This review is dedicated to Prof. Dr. Gerhard Buchbauer on the occasion of his 80th birthday.

Abstract: Essential oils have been used by indigenous peoples for medicinal purposes since ancient
times. Their easy availability played an important role. Even today, essential oils are used in
various fields—be it as aromatic substances in the food industry, as an aid in antibiotic therapy, in
aromatherapy, in various household products or in cosmetics. The benefits they bring to the body and
health are proven by many sources. Due to their complex composition, they offer properties that will
be used more and more in the future. Synergistic effects of various components in an essential oil are
also part of the reason for their effectiveness. Infectious diseases will always recur, so it is important
to find active ingredients for different therapies or new research approaches. Essential oils extracted
from the bark of trees have not been researched as extensively as from other plant components.
Therefore, this review will focus on bringing together previous research on selected bark oils to
provide an overview of barks that are economically, medicinally, and ethnopharmaceutically relevant.
The bark oils described are Cinnamomum verum, Cedrelopsis grevei, Drypetes gossweileri, Cryptocarya
massoy, Vanillosmopsis arborea and Cedrus deodara. Literature from various databases, such as Scifinder,
Scopus, Google Scholar, and PubMed, among others, were used.

Keywords: Cinnamomum verum; Cedrelopsis grevei; Drypetes gossweileri; Cryptocarya massoy;

Citation: Graf, M.; Stappen, I. Vanillosmopsis arborea; Cedrus deodara; bark; essential oils
Beyond the Bark: An Overview of the
Chemistry and Biological Activities
of Selected Bark Essential Oils.
Molecules 2022, 27, 7295. https:// 1. Introduction
doi.org/10.3390/molecules27217295 Essential oils (EO) are found in various parts of plants like leaves, roots, seeds, fruits,
Academic Editor: Horváth Györgyi as well as bark and wood. They are secondary metabolites and therefore may occur in
some species or parts of the plant and not or less in others. Depending on the location or
Received: 28 September 2022 the soil properties the plant grows in and depending on the species, the plant produces
Accepted: 25 October 2022
EOs with different composition and properties. [1,2] Chemically, EOs mainly consist of
Published: 27 October 2022
mono- and sesquiterpenoid hydrocarbons as well as phenylpropanoids that are biosyn-
Publisher’s Note: MDPI stays neutral thesized in the plants via phosphoenolpyruvate. From this key building block, terpenoids
with regard to jurisdictional claims in are formed by the mevalonic acid- or the methyl erythritol phosphate pathways. Their
published maps and institutional affil- basic structural element is the isoprene unit; monoterpenoid hydrocarbons comprising of
iations. two, sesquiterpenoid hydrocarbons of three units. Phenylpropanoids are derived by the
shikimic acid pathway, representing the aromatic fraction of the EO. These main structures
further can be oxygenated to alcohols, ethers, aldehydes, ketones, and acetates. [2,3] Plants
produce these highly volatile, lipophilic, and very complex multi-component mixtures
Copyright: © 2022 by the authors.
as a defense mechanism against microorganisms, predators, and pests, but also to attract
Licensee MDPI, Basel, Switzerland.
pollinators [1]. In most cases, one to four main compounds make up to 90% of the oil,
This article is an open access article
whereas the concentration of the other components are significantly lower [3]. Extraction
distributed under the terms and
methods for obtaining EO have evolved considerably in recent years. Several new ex-
conditions of the Creative Commons
Attribution (CC BY) license (https://
traction methods have significantly improved the quality, purity and yield of the oils and
creativecommons.org/licenses/by/
facilitated their analysis [2]. But they also played a major role in earlier times. There are
4.0/).
records of the Persians using simple equipment for hydrodistillation as early as 3500 BC,

Molecules 2022, 27, 7295. https://doi.org/10.3390/molecules27217295 https://www.mdpi.com/journal/molecules

Molecules 2022, 27, 7295 2 of 17

which underscores the importance of these EOs for centuries. Especially in the context
of traditional use, herbal medicine is more accessible to most people than conventional
medicine. EOs are used against a wide range of diseases and are particularly appreciated
for their multiple properties. As for the various bark oils and their main components to
be presented here, these properties include antimicrobial, insecticidal, anti-tyrosinase, and
antioxidant activities. However, often not only one main component of the EO is involved
in the mechanism of action, but there is a synergistic effect between several components of
the oil. EOs also play an increasingly important role in modern medicine. In view of the
increasing resistance to antibiotics and emerging infectious diseases, EOs appear to have
great potential for future applications and development in terms of their antibiotic and
also efficacy-enhancing properties [4]. However, it is not only the pharmacological sector
that is interested in the study of EOs. The anti-inflammatory properties and non-toxicity
that some EOs exhibit are also used in cosmetics. In the cosmetic and perfume industry,
EOs additionally play an important role due to their unique odor [5]. The food industry
also tries more and more to limit the use of conventional antibiotics and replace them with
natural substances. The approach of using EOs as additives seems to bring good results.
Agriculture also benefits from their repellent or larvicidal activity as new insecticides [6].
The various healing properties of these oils have already been used by indigenous peoples
and are increasingly being explored for other purposes. In the course of this review, bark
EOs of selected trees have been viewed regarding their chemistry, their different properties
and fields of application, as well as their prospect to the future medical development. These
trees are: Cinnamomum verum, Cedrelopsis grevei, Drypetes gossweileri, Cryptocarya massoy,
Vanillosmopsis arborea and Cedrus deodara. They were chosen for their economic but also for
their ethnopharmaceutical importance as well as their unique chemical composition. An
overview of their main activities described in this review is listed in Table 1. Moreover,
their main constituents—listed in Figure 1—as well as the EOs compositions regarding
their variations are discussed.

Table 1. Major biological activities of selected bark EOs.

Essential Bark Oil

Biological Activity (Model) References
(Plant Family)
anticoagulant (in vitro) [7]
antimicrobial (in vitro) [8]
Cinnamomum verum J. Presl antidiabetic (in vitro) [9]
(Lauraceae) anti-Alzheimer (in vitro) [10]
antioxidant (in vitro) [11]
neuroprotective (in vitro) [12]
anti-cancer (in vitro) [8]
anti-inflammatory (in vitro) [13]
antioxidant (in vitro)
Cedrelopsis grevei Baill. [14]
antibacterial (in vitro)
(Ptaeroxylaceae)
anti-cancer (in vitro)
antibacterial (in vitro) [15–17]
Drypetes gossweileri S. Moore
antioxidant (in vitro) [18]
(Euphorbiaceae)
anti-inflammatory (in vitro) [18]
anti-biofilm (in vitro) [19,20]
Cryptocarya massoy (Oken) antibacterial (in vitro) [21]
Kosterm. immunomodulatory (in vitro) [20]
(Lauraceae) anti-inflammatory (in vitro) [20,22]
blood-fat-reducing (in vivo) [23]
antibacterial/antibiotic-synergistic (in vitro) [24–27]
Vanillosmopsis arborea Barker gastroprotective (in vivo) [28]
(Asteraceae) antinociceptive (in vivo) [29]
anti-inflammatory (in vitro) [30]
Molecules 2022, 27, 7295 3 of 17

Table 1. Cont.

Essential Bark Oil

Biological Activity (Model) References
(Plant Family)
antifungal (in vitro) [31]
Cedrus deodara (Roxb. Ex. D. antibacterial (in vitro) [32]
Molecules 2022, 27, x FOR PEER REVIEWDon) G. Don (Pinaceae) insecticidal (in vitro) [33]3 of 18
gastro-protective/anti-ulcer (in vitro) [34]

cinnamaldehyde (a) eugenol (c)

cinnamyl acetate (b)

linalool (e) β-caryophyllen (f)

α-pinene (d)

α-bisabolol (g) benzyl cyanide (i)

benzyl isothiocyanate (h)

cis-ocimene (k)
C10 massoia lactone (j) longifolene (l)

α-himachalene (m) β-himachalene (n) γ-himachalene (o)

Figure 1. Chemical structures of principal constituents of selected barks and wood.

Figure 1. Chemical structures of principal constituents of selected barks and wood.
Table 1. Major biological activities of selected bark EOs.

Essential Bark Oil (Plant Family) Biological Activity (Model) References

anticoagulant (in vitro) [7]
antimicrobial (in vitro) [8]
Cinnamomum verum J. Presl antidiabetic (in vitro) [9]
(Lauraceae) anti-Alzheimer (in vitro) [10]
Molecules 2022, 27, 7295 4 of 17

2. Essential Oils of Selected Barks

2.1. Cinnamomum verum J. Presl (Lauraceae)
C. verum, also known as C. zeylanicum Blume, is an evergreen tree found in Asia and
Australia that can reach a height of 20 m [11,35]. The trees are characterized by leathery,
ovate leaves that have three prominent veins. They turn from reddish to dark green
depending on age. The inflorescence of pale-yellow flowers is axillary or in terminal
panicles. The fruit is a dark purple to black colored ovoid drupe. During rainy periods
the 3–4-year-old stems are cut off to make the bark easier to peel off. The outer skin
of the bark is removed, and the remaining bark is rubbed off with a brass block. A
special round knife is then used to obtain the compound quills of the cinnamon. The
quills are dried and then disinfected with sulfur dioxide, which also is the reason for the
golden hue of the quills [35]. The genus Cinnamomum includes about 250 species that
grow mainly in Asia and Australia. The main cultivation of C. verum takes place in its
country of origin, Sri Lanka [36]. From there, cinnamon is exported to various countries
around the world [11]. Records show that exportation began as early as the 16th and 17th
centuries. The uses of cinnamon seem almost limitless; for centuries it has been a valued
spice. It is also used in Ayurvedic medicine and was used for mummification in ancient
Egypt. The biological properties of the Cinnamomum genus are enormous. Several studies
show its antimicrobial, insecticidal, acaricidal, antityrosinase, antimycotic, anticancer, anti-
inflammatory, antidiabetic, antioxidant and antimutagenic activities [8,37]. C. verum is also
used as scent for perfumes [9].
A GC-MS analysis of hydrodistilled C. zeylanicum bark purchased in Turkey identified
nine different compounds of the EO: (E)-cinnamaldehyde (68.95%; Figure 1a), benzalde-
hyde (9.94%), (E)- cinnamyl acetate (7.44%; Figure 1b), limonene (4.42%), eugenol (2.77%
Figure 1c), α-pinene (1.64%; Figure 1d), 1,8-cineol (1.55%), linalool (1.38%; Figure 1e) and
(E)-cinnamic acid (1.15%). In particular, the major constituent (E)-cinnamaldehyde showed
different variations with respect to its total content in the EO. Depending on where the plant
material was collected, the content of the individual components of the oil also differed [8].
Two different studies analyzed plant material of C. zeylanicum bark collected from
different parts in Turkey. Nine different compounds were isolated in one study and
22 compounds were isolated in the other study. In both GC-MS analyses (E)- cinnamalde-
hyde and (E)-cinnamyl acetate were among the main compounds [8,10].
The hydrodistilled Cinnamomum EO showed anticoagulant effects, while the aqueous
extract of the same bark showed no reduction in clotting time in a blood test, suggesting
that the active ingredient seems to be a component of the EO. The authors could not fully
determine exactly which component was responsible for this biological effect, due to the
complexity of the oil [7].
To evaluate antimicrobial activity, Unlu et al. [8] tested the EO against 21 bacteria and
four Candida species. Screening against the bacteria and yeasts of interest for their mini-
mum inhibitory concentration (MIC) using the disc diffusion method (DDM) showed the
high efficacy against Gram-positive (Staphylococcus, Streptococcus, Enterococcus) and Gram-
negative (Pseudomonas aeruginosa) bacteria as well as against different Candida strains. The
components responsible for the antibacterial property were identified as cinnamaldehyde
and eugenol, which are both phenylpropanoids and known for their high antimicrobial
potential [3]. They either damage the cell walls of the bacteria or inhibit an essential
enzyme—or even both [8]. Cinnamaldehyde is also used in periodontal disease. Its an-
timicrobial activity has been demonstrated in many studies. High biological activities are
attributed to this component throughout the genus Cinnamomum, as reviewed by Wang
and coworkers [38].
In the context of antidiabetic activity, results are biased, some studies reporting
stronger inhibition of α-amylase by the EO, others weaker. Interestingly, the inhibitory
effect of the whole oil on this enzyme was 15.25%, whereas the isolated substances (E)-
cinnamaldehyde and (E)-cinnamyl acetate exhibited an α-amylase-inhibition of 21.30%
and 7.29%, respectively. Different ratios of (E)-cinnamyl acetate to (E)-cinnamaldehyde
Molecules 2022, 27, 7295 5 of 17

were tested. The inhibition of the enzyme increased by up to 38.74%. This was the highest
measured α-amylase inhibitory activity obtained in this study by different mixtures of the
individual components of the EO [10].
In the field of Alzheimer’s disease, in a study by Tepe and Ozaslan, the oil and both
main compounds of the oil showed comparable results in the inhibition of MAO-A and
MAO-B with rasagiline, as well as a 99.0 % inhibitory effect on cholinesterases. The EO
and (E)-cinnamaldehyde therefore seem to have great potential for the future treatment
of Alzheimer’s disease [10]. Natural antioxidants play an important role in nutrition and
are believed to prevent many diseases, including cancer. Additionally, they are used in
the food industry to limit food spoilage [37]. An in vitro study of antioxidant properties
showed inhibition of 3-nitrotyrosine formation by the EO and eugenol with IC50 values of
18.4 µg/mL and 46.7 µM/mL, respectively. In contrast, (E)-cinnamaldehyde and linalool
showed no activity in inhibiting peroxynitrite-induced nitration and lipid peroxidation [11].
The neuroprotective activity of C. zeylanicum EO was also demonstrated in an in vitro
model testing the viability of PC12 cells and reactive oxygen species after exposure to 6-
hydroxydopamine. Pretreatment of PC12 cells with the EO and its main compound cin-
namaldehyde reduced ROS and cytochrome C and increased survivin. This demonstrated
efficacy against the cytotoxicity of 6-OHDA by inhibiting the p44/42 pathway in PC12 cells
suggesting future application in the treatment of Parkinson’s disease. [12]
An MTT (3-(4,5-Dimethylthiazol-2-yl)-2,5-diphenyltetrazoliumbromid) assay was pre-
pared to access the EOs’ future use in tumor therapy. A dose above 15 µg/mL of EO
was able to show cytotoxicity against cell lines 5RP7 (H-ras active-rat fibroblasts) and
F2408 (normal rat fibroblasts). The time-dependent cytotoxicity towards H-ras-active cells,
which was also found, could probably indicate an application in ras-oncogene-induced
carcinomas, which has also been demonstrated for monoterpenes such as limonene. [8,39]
However, further studies need to be conducted to confirm this activity. The authors of the
study also described that low concentrations of the oil induced controlled cell death and
high doses induced necrotic death [8].
Further investigations tested the anti-inflammatory effects and tissue remodeling of
C. verum EO. Biomarker proteins for inflammatory processes such as vascular cell adhesion
molecule-1 (VCAM-1) and intercellular cell adhesion molecule-1, as well as epidermal
growth factor receptor (EGFR), matrix metalloproteinase 1, and plasminogen activator
inhibitor-1 could be inhibited by the EO. An immunomodulatory effect on macrophage
colony-stimulating factor was also noted. Some signaling pathways that trigger inflamma-
tory responses could be inhibited. Although many studies sound very promising, further
studies are needed to determine clinical application and safety [13].

2.2. Cedrelopsis grevei Baill. (Ptaeroxylaceae)

C. grevei is a tree native to Madagascar, which is one of the most species-rich regions
of the world. Malagasy people turned to natural medicine for a variety of reasons. One is
because of the high cost of drugs in modern medicine, whereas another is a social aspect.
As a result, minor injuries and illnesses tend to be healed by community elders and major
illnesses are then taken care of by traditional healers, some of whom rely on the local
flora. According to research on the most commonly used medicinal plants in Madagascar,
C. grevei is one of the species with the greatest utility value [40]. The EO extracted from
the bark of the tree, which grows up to 15 m high is also known as “katrafay”. Samples
from different studies showed great variability in terms of EO composition. In one of
their publications, Rakotobe and coworkers examined the hydrodistillation of 21 different
bark samples from six different regions in Madagascar. They concluded that at least one
of the samples contained 71 volatiles, eleven of which totaled about 10% of the oil. The
most important compounds besides (E)-β-caryophyllene (Figure 1f) and caryophyllene
oxide were monoterpene hydrocarbon α-pinene, sesquiterpene hydrocarbons α-copaene,
ishwarane, selinenes, cadinenes, and oxygenated sesquiterpenes copaborneol, T-muurolol,
α-cadinol, α- and γ-eudesmols, and α-bisabolol (Figure 1g). The difference between these
Molecules 2022, 27, 7295 6 of 17

results and another analysis of bark oil was that no cis-sesquisabine hydrate was found
in that case. Rakotobe et al. also concluded that there are four distinct chemotypes that
show their variability in EO composition probably due to differences in native soils [41].
Gauvin et al. analyzed the EO derived by steam distillation of the bark by GC-MS and
found β-pinene (17.1%), cis-sesquisabinene hydrate (12.8%), caryophyllene oxide (7.0%)
and δ-3-carene (4.2%) as main compounds [42].
Already in 2003, in the first report on the composition of the bark oil of C. grevei by
Cavalli et al., the variability of this EO was noted. In one sample, (E)-β-caryophyllene (9.3%),
α-copaene (7.7%), α-selinene (5.8%), δ-cadinene (4.9%), β-selinene (4.5%), α-humulene
(3.3%), and β-bisabolene (2.8%) were detected. Over 114 compounds were identified. The
main components ishwaren and (E)-β-caryophyllene were also found in other samples.
Overall, all studies confirm the main occurrence of sesquiterpene hydrocarbons in the bark
oil of C. grevei [43].
The EO was described by a perfumer from France as an amber oil with the odor
of terpene hydrocarbons with woody, spicy, green, chypre and oriental notes [42]. The
Malagasy use the bark of the trunk for various ailments. These include muscle fatigue
and reduction of capillary fragility. It is also used as an ingredient in a cough syrup
against persistent catarrh or in anti-hypertensive beverages according to the Madagascan
pharmacopoeia [14,44,45]. Aphrodisiac properties have also been described [40]. The bark
is further used for rheumatism or pulmonary and cardiovascular diseases, as well as a
febrifuge. In addition, antifungal and antibiotic properties were reported [14].
It seems that the widespread benefits of the EO can be attributed to the terpene compo-
sition it contains. To conduct further studies on the biological activities, Tardugno et al. [14]
performed a DPPH (2,2- diphenyl-1-picrylhydrazyl) assay and an ABTS+ spectrophoto-
metric assay (2,20 - azino-bis (3-ethylbenzothiazoline-6-sulfonic acid)). For this purpose, the
EO was divided into three different fractions. The entire EO was also examined. C. grevei
EO showed a percentage inhibition of the radical scavenger of 4.65 ± 0.03, while Trolox
as a positive control showed an inhibition of 54.10 ± 0.22%. The ABTS activity of the EO
showed an inhibition of 19.41 ± 1.22% compared to the control of 98.40 ± 4.10%. The
fraction containing the oxygenated sesquiterpenoids as components indicated a particularly
significant increase in antioxidant activity: 4.78 ± 0.13 % in the DPPH and 88.56 ± 4.38 %
in the ABTS+ assay [14].
Inhibition of microbial growth was determined using various human bacterial strains,
yeasts, and dermatophytes. A closer look at the inhibition of bacterial growth by C. grevei
EO revealed differences depending on the bacterial strain used. For Escherichia coli and
P. aeruginosa it showed MIC values of >1.90 mg/L, for Staphylococcus aureus and S. epidermidis
MIC values of 0.47 mg/L, respectively, and for E. faecalis a MIC of 0.95 mg/L was found.
As a positive control the antibiotic chloramphenicol was used, which showed MIC values
of 6.2 mg/L for P. aeruginosa, 25 mg/L for E. coli and 3.1 mg/L for S. epidermidis and
S. aureus, respectively. Thymus vulgaris L. (Lamiaceae) EO, as a second positive control,
demonstrated MIC values reaching from 0.5 to >2.00 mg/L. Thus, C. grevei EO showed a
higher antibacterial activity compared to positive controls. In contrast to these findings,
the EO of C. grevei did not indicate efficient growth inhibition on C. albicans as yeast and
dermatophytes such as Micosporum gypseum, Nannizzia gypsea, Tricophyton mentagrophytes
and T. tonsurans. However, the fraction of oxygenated sesquiterpenoids delivered selective
activity against Gram-negative bacteria. Tardugno et al. concluded that this could be
due either to the high percentage of oxygenated mono- and sesquiterpenoidss or also to
a possible synergistic effect of the compounds in this fraction, which contained mainly
sesquiterpene-alcohols palustrol, ledol, elemol and cubenol, as well as monoterpene-alcohol
α-terpineol [14].
Finally, an MTT assay was performed to determine the effect on viability of A549 and
CaCo-2 cancer cell lines. The EO showed an IC50 (µg/mL) value of 27.08 ± 1.90 against the
A549 cancer cells and 54.06 ± 3.12 µg/mL against the CaCo2 cell line. Since the IC50 value
(µg/mL) for A549 cancer cells was less than 30, the cytostatic property of this EO may have
Molecules 2022, 27, 7295 7 of 17

more practical uses and applications in the future. However, more research is needed for
this purpose [14].

2.3. Drypetes gossweileri S. Moore (Euphorbiaceae)

D. gossweileri, also known locally as the “horseradish tree”, is a tree common in the
Democratic Republic of Congo, Gabon, Equatorial Guinea, the Central African Republic
and Cameroon. This tree plays an important role in traditional medicine of the mentioned
countries [46]. It can reach a height of up to 42 m. The bark has a grey color and a pungent
smell of horseradish [47].
Traditionally, the bark is used in many ways: as an analgesic, antipyretic and ver-
mifuge; as a genital stimulant and depressant, but also against various pains, such as
headaches, rheumatism, and toothache. It is also reported that the bark is applied against
malaria, gonorrhoea and typhoid fever. Additionally, it is used in poison-fishing [46].
A GC-MS analysis of the EO of the bark by Agnaniet et al. identified eleven different
components. During the distillation period of six hours, the oil was analyzed at different
time points. After the six-hours distillation time, a large amount of decomposition products
of glucosinolates was detected. Benzyl cyanide with 19.4% at 0.5 h and 73.7% after 6 h
distillation was probably formed by the reaction between the cyanide ions and benzyl
isothiocyanate (72.0% at 0.5 h and reached 5.2% at 6 h) [47].
In addition to benzyl isothiocyanate (Figure 1h) and benzyl cyanide (Figure 1i), the
components in the bark oil were benzaldehyde (0.8%), benzyl alcohol (10.8%), benzyl for-
mate (0.6%), linalool (0.6%), benzyl acetate (0.7%), β-caryophyllene (0.3%), caryophyllene
oxide (0.3%), benzyl benzoate (0.2%), and benzyl salicylate (1.1%). The numbers indicate
the percentage after six hours distillation and account for 93.4%. According to the result
from GC-MS, the terpenes made up only a small part of the EO. Agnaniet et al. stated
that the high content of benzyl alcohol probably showed that it emerged from benzyl
isothiocyanate and not from the hydrolysis of the glucosinolates [47].
An EO analysis of horseradish bark harvested in Hawae and Ngomedzap (central
region of Cameroon), with an EO extraction yield of 0.04% and an identified total content
of 99.70%, showed the major constituent benzyl isothiocyanate in an amount of 63.19%,
instead of benzyl cyanide, which accounted for 35.72% in that study. This differed from
the study of Agnaniet et al. but can be explained by regional differences since this plant
material was collected in the Nkomo-Moanda region [18,47]. In another study examining
the main constituents of EO obtained from bark in Gabon and in the Central African
Republic, benzyl isothiocyanate was the major compound in both reports. The EO of
plants harvested in Gabon contained 1.3% benzaldehyde, 42% benzyl cyanide and 56.5%
benzyl isothiocyanate. The plant material from the Central African Republic contained
0.2% benzaldehyde, 5.7% benzyl cyanide and 93.9% benzyl isothiocyanate. These results
support the research outcome from other studies [48].
The food industry is very interested in finding natural antibiotic agents to reduce food
spoilage caused by spore-forming bacteria. The toxins of some species can cause food
poisoning. In addition, some of these pathogens often exhibit increased stability even at low
temperatures or pH levels, making common sterilization methods difficult and not always
possible if one wants to preserve the nutritional value and odor of the food. Therefore, a
study was conducted to investigate the effect of D. gossweileri bark oil on the formation of
Bacillus spores. Three different Bacillus species were used for this purpose (Bacillus cereus T,
B. subtilis NCTC, B. megaterium 8174). Inhibition of spore germination was demonstrated
by a macrodilution assay. MICs of the EO were determined for B. cereus T at 9 µg/mL, B.
subtilis NCTC at 9 µg/mL, B. megaterium 8174 at 4 µg/mL. Further, the MICg (minimal con-
centration inhibiting germination of spores) of the three species were at 2 µg/mL, 1 µg/mL
and 2 µg/mL, respectively. The EO also inhibited the germination and vegetative growth
of spores of Geobacillus stearothermophilus. The MIC for this bacterium was 9 µg/mL. D.
gossweileri therefore showed a stronger antimicrobial activity compared to other EOs in the
study, such as T. vulgaris or Zingiber officinale Roscoe (Zingiberaceae). Various combinations of
Molecules 2022, 27, 7295 8 of 17

the EO of D. gossweileri with other EOs, like Syzygium aromaticum (L.) Merr. and L.M. Perry
(Mytraceae) EO, were able to enhance antibacterial activity, which the authors attributed to
the synergistic effect of benzyl isocyanate and other active compounds. Phenylpropanoids
thymol and eugenol, as well as terpenoid hydrocarbons trans-β-caryophyllene and neral
found in the combined EOs, seemed to support the transport of benzyl isocyanate into the
cell [15].
Concentrations of 0.25, 0.5, and 1 µg/mL of D. gossweileri bark EO in orange juice
and milk demonstrated increased sensitivity of spores to radiation sterilization procedures,
which could be valuable to the food industry in the future. The authors suggested that
the increased UV sensitivity to spores was due to the photosensitizing effect of benzyl
isothiocyanate. The increased reactivity of this constituent could lead to binding to DNA
and, with increased energy absorption trough exposure of UV, increased breakage and ROS
formation. However, the characteristics of the food used also influences the sensitivity of a
bacterium to EO. A stronger anti-spore effect was observed in milk than in orange juice.
This could be due to the different pH values (orange juice: 4.65 versus milk: 6.75). A low
pH increases the hydrophobicity of EO, thus facilitating access to the germinant receptors
in the spore membranes. The high content of protein and high lipid concentration in the
milk probably also plays a role in the mode of action. Nevertheless, it should be noted that
the high concentration of isothiocyanates, which have a particularly strong pungent odor
and taste, may be undesirable in food. However, in this study, only a slight change in the
taste or odor of the orange juice was observed at 2.5 µg/mL, but a significant change was
noted at 10 µg/mL [16].
The bark EO of D. gossweileri was further investigated for its antioxidant and an-
tiinflammatory properties by Ndoye Foe et al. [18]. For this purpose, a DPPH radical
scavenging assay was performed and the EO showed an antioxidant activity index (AAI)
of 12.821 (scavenging concentration (µg/mL) was 0.20), which was ten times higher than
that of ascorbic acid (AAI = 1.262 and SC50 of 1.98 µg/mL (SC50 = concentration of sample
required to scavenge 50 % of free radicals)). According to the criteria of Scherer and Godoy
AAI > 2 means that it has a very strong antioxidant activity [49]. The authors concluded that
the antioxidant properties probably were caused by synergetic effects between different
components in the oil. The ferric reducing capacity of D. gossweilei EO was reported to
be 0.76 ± 0.03 µg AAE/mg (ascorbic acid equivalent per mg EO) and the total phenolic
content was 365.38 ± 0.66 µg AAE/mg. Anti-inflammatory activity was determined by
bovine serum albumin anti-denaturation assay. D. gossweileri bark EO showed an IC50
value (µg/mL) of 88.30 compared to a 104.44 µg/mL IC50 value of diclofenac sodium [18].
Another study showed antimycobacterial activity of D. gossweileri bark EO against
virulent strain H37Rv and two isolates IS53 and IS310 of Mycobacterium tuberculosis. The EO
exhibited cell membrane lysis and DNA inhibition. Disruption of cellular homeostasis by
structural changes in the membrane and cell wall caused bacterial death. The MIC values
(µg/mL) against H37Rv, IS53 and IS310 were 4.88, 9.76 and 4.88, respectively. In contrast,
no mycobacterial activity was detected against the multidrug resistant and extensive
drug resistant MJ and UJ isolates and the isoniazid resistant isolate AC79. Against the
rifampicin resistant isolate AC45, the bark EO showed moderate activity with a MIC of
156.25 µg/mL [17].

2.4. Cryptocarya massoy (Oken) Kosterm. (Lauraceae)

C. massoy., also known as C. aromatica (Becc.) Kosterm. or Massoia aromatica (Becc.), is
an evergreen tree found in Papua New Guinea and Indonesia [21]. It grows up to 15–30 m
tall. The bark is characterized by its smooth, greenish, or light grey appearance. It has a
thickness of 5–15 mm [50]. The EO ingredients from the wood and especially the bark of
the tree are popular in perfumery. The oil is also said to have antifungal and insect repellent
properties. In addition, it is used as a natural coconut flavoring in food products. Since
the aroma can also be perceived as butter-, cream- or milk-like, it is also used in the food
industry as milk aroma [21,23,51].
Molecules 2022, 27, 7295 9 of 17

Traditional uses of the bark include stomach cramps during pregnancy, post-pregnancy
recovery, and fever. It further is applied as a tranquillizer/sedative, to stimulate sex
hormones, as a tonic, as an antispasmodic, and as an anthelmintic [50]. It is part of an
indigenous herbal medicine from Indonesia called “pilis” to restore vitality and stimulate
recovery after childbirth [52].
An analysis of the EO of the bark identified over 20 constituents. Of the 98.61%
identified oil massoia lactones were the main components of the EO. This term describes
α, β-unsaturated δ-lactones. Some of them could be chemically identified: C-10 massoia
lactone (5,6-Dihydro6-pentylpyran-2-one; Figure 1j) with a 56.25% relative content, C-12
massoia lactone (5,6- Dihydro-6-heptylpyran-2-one) with 16.51%, C-8 massoia lactone
(5,6-Dihydro-6-propylpyran2-one) with 3.4% and C-14 massoia lactone (5,6-Dihydro-6-
nonylpyran-2-one) with 0.56%. Additionally, the saturated compounds δ-decalactone
(1.53%), δ-dodecalactone (0.49%), tuberolactone (0.67%) were identified. Benzyl benzoate
(12.72%) and benzyl salycilate (1.79%) as aromatic esters are also part of the EO. It is
very interesting that common dimethylallyl pyrophosphate or phenylpropanoid pathway
derivatives were hardly detected in the EO of the bark. No typical monoterpenes and
sesquiterpenes are found, which distinguishes this EO from others. The entire Cryptocarya
genus has very unique secondary metabolites [21]. A comparative study of the bark and
heartwood oils again revealed C-10 massoia lactone as the main constituent of the bark EO,
as well as C-12 massoia lactone and benzyl benzoate. In contrast to the previous analysis, a
very small amount of linalool, borneol and β-bisabolene were found in the bark oil. The
heartwood oil also contained C-10, C-12, and C-14 massoia lactones and δ-decalactone [53].
In addition to Cryptocarya, massoia lactones can also be found in Aeollanthus suaveolens
Mart. ex Spreng. (Lamiaceae), Baccharis magellanica Pers. (Asteraceae), Isolona cooperi Hutch.
and Dalziel ex G.P.Cooper and Record (Annonaceae), and Cenchrus macrounrus (Trin.) Mor-
rone (cattail balm; Poaceae). In addition, they are part of the defense substances of two ant
species (genus Camponotus) [21], C-10 massoia lactone being the most important one in the
ants’ defense mechanism [53].
In particular, the massoia lactones and benzyl esters in the EO have shown phototoxic
properties against the germination and growth of Lycopersicon esculentum Mill. (Solanaceae)
and Cucumis sativus L. (Cucurbitaceae) plantlets, which were used in a study as representa-
tives of typical target plants for herbicides. They were equivalent to or better than EO in
commercial weed and pest control products [21,51].
As for antifungal activity, C. massoy EO showed potential as an anti-biofilm compound.
C. albicans causes many opportunistic infections, especially in people with compromised
immune systems. It can form biofilms that are very difficult to treat because they can also
grow on medical devices such as implants, catheters, and ventilators. Therefore, the way
of action the EO affects the formation and degradation of biofilms was investigated. It
was found that C. massoy bark EO showed synergistic effects with several other EOs, such
as Cinnamomum burmanii (Nees and T. Nees) Blume (Lauraceae) and Ocimum basilicum L.
(Lamiaceae), in the intermediate phase of C. albicans biofilm. Further synergistic effects
with the EO of C. burmanii and Citrus hystrix D.C. (Rutaceae) in the mature phase were
reported [19]. In another study, anti-biofilm activity, specifically of the C-10 massoia lactone,
against C. albicans showed an IC50 of 0.026 µg/mL [20]. The antimicrobial activity of the
EO of the bark was tested against four phytopathogenic bacteria. Agrobacterium tumefaciens,
A. vitis, Clavibacter michiganensis and Pseudomonas syringae. The EO showed MIC (µL/L)
values of 250, 2000, 250 and 125, respectively. S. aromaticum EO was used as reference and
showed MIC (µL/L) values of 250, 2000, 1000 and 500, respectively [21]. Breakpoints of
MIC values for EOs have not been defined so far, impeding the interpretation of reported
antibacterial activities. Comparing drugs with EOs, a MIC value of 2000 is rather high
and therefore indicates low to no activity. In our opinion it could be concluded that
C. massoy EO showed a promising effect against A. tumefaciens, C. michiganensis and P.
syringae, but was inactive against A. vitis. S. aromaticum indicated a good effect against
A. tumefaciens and a fair antimicrobial activity against C. michiganensis and P. syringae.
Molecules 2022, 27, 7295 10 of 17

However, another problem in the evaluation of antimicrobial activity of EOs is the fact,
that research groups use different methods to determine antimicrobial activity, making a
comparison of results impossible. For future research in this important field it would be
necessary to create and use standardized methods. The immunomodulatory effect of C.
massoy EO was demonstrated using an in vitro mouse macrophage phagocyte assay. The
response of macrophages to latex beads and C. albicans was observed. The oil and lactone
successfully increased the phagocytosis activity of macrophages and inhibited C. albicans.
In an in vitro lymphocyte proliferation assay, no proliferative effect on lymphocytes was
observed. A Cytotoxicity assay with the bark EO and the isolated C-10 massoia lactone
revealed concentration dependent cytotoxicity to the test cell lines. Vero and primary
culture of fibroblast cells were used. In fibroblast cells, the IC50 of C10 massoia lactone and
EO were 11.29 µg/mL and 26.07 µg/mL, respectively. The IC50 values of Vero cells were
28.35 µg/mL (C-10 massoia lactone) and 37.34 µg/mL (EO), respectively. The study results
indicated that massoia oil and its isolated main compound C-10 massoia lactone seems to
have the capability as an immunmodulator [20].
The α,β-unsaturated δ-lactone structure, which is also part of massoia lactones, plays
a central role in various studies on anti-inflammatory and immunomodulatory properties.
They are considered to be cytotoxic. In particular, C-10 massoia lactone is thought to be
responsible for cytotoxic effects on different cancer cell lines [20,22]. This structural part
is found in various components of plants and marine organisms and many of them have
specific biological activities. Therefore, because of its particularly simple structure, further
reports on the (-)-massoia lactone from the bark of C. massoy may provide more informa-
tion on future syntheses of various complex natural products that also include this core
functional group. Further modification of the core structure may lead to the preservation
of various biological properties of already known complex natural products [22].
Batubara et al. studied the effects of C. massoy EO and its major constituent massoia
lactones after inhalation in Dawley rats in vivo. The animals that inhaled the fraction of
EO rich in massoia lactones reduced their body weight due to the appetite suppressant
effect it showed. It also prevented fat deposition in liver cells. It further was found that the
fractionated EO had a limiting effect on triglycerides and cholesterol concentration in the
blood [23].
The fear that C. massoy could be overharvested because of its many uses as a medicine
and in food industry is pervasive. In Indonesia, C. massoy EO is the eighth most pro-
duced EO. However, studies show that it is possible to grow C. massoy outside its natural
habitat [54].

2.5. Vanillosmopsis arborea Barker (Asteraceae)

V. arborea, also known as “Candeeiro”, is a tree native to Brazil, especially in the
Caatinga biome in the northeast. It plays an important commercial role due to the ingredi-
ents that can be extracted from it [24]. Many studies on the bark EO have shown larvicidal,
antileishmanial, antimicrobial, antimicrobial, anti-inflammatory, antinociceptive, and gas-
tric protective activities. More cultural uses are documented of this tree, for example it is
said to repel mosquitoes. It is also discussed to use the EO as an adjuvant in the treatment
of respiratory bacterial infections in combination with antibiotics [24]. The analysis of the
EO of the bark of V. arborea by Teixeira et al. showed that α-bisabolol (70%), α-cadinol
(8.4%), elemicine (6.21%), β-bisabolene (4.46%), δ-guaiene (2.31%), β-cubebene (1.76%) and
estragole (1.08%) were the main parts of its chemical composition [24].
Due to environmental conditions, which—besides others—include age, water avail-
ability or seasonality, there are differences in the proportions of the main components in
different EO analyses [24]. This is also evident from further photochemical analysis in other
studies with the components (-)-α-bisabolol (97.9%), methyl eugenol (1.6%), and bisabolol
oxide (0.5%) [29]. Another investigation performed by Santos et al. [25] again confirmed
α-bisabolol as the main constituent of the stem oil with 80.47%. Other components were
ethyl propanoate (5.87%), propyl ethanoate (9.00%), o-methyleugenol (2.39%) and bisabolol
Molecules 2022, 27, 7295 11 of 17

oxide (2.31%). 24 Sesquiterpenoids such as α-bisabolol, found in high concentrations in

EO, are also often associated with pheromone, insect repellent, or phytoalexin properties.
α-Bisabolol plays an important role in cosmetics due to its skin-healing properties. As
mentioned earlier, low toxicity and anti-inflammatory activity are the properties that make
these compounds so attractive for further research and wide use in medicine. Efforts are
being made to use fewer and fewer antibiotics to counteract the development of resistance.
The mechanism of action of EOs is based on the destabilization of the bacterial cell wall to
achieve better absorption of the antibiotic. The particularly hydrophobic property of the
EO plays a major role in this process. Tests indicated a synergistic effect of the EO of V.
aroborea with the antibiotic gentamycin on the strain of P. aeruginosa. At the same time, in
the same experiment, the effect of EO together with tetracycline and tobramycin did not
show increased efficacy of the respective antibiotic. Therefore, V. aroborea EO seems to have
potential as an enhancer in antibiotic therapy [25].
An animal experiment in which oral doses of 200 mg/kg and 400 mg/kg of bark
EO were administered per os to male albino mice, was performed by De O Leite and
coworkers [28]. Results showed a significant effect of the oil on ethanol-induced gastric
lesions in the experimental animals. The authors concluded from the series of experiments
that an agonism of the peripheral α2-receptor is likely to be considered as part of the
mechanism of gastroprotection [28]. Peripheral antinociceptive activity and an antipruritic
effect were demonstrated by Leite et al. with various tests in male mice [29]. Other animal
studies described the analgesic and anti-inflammatory effects of the EO. A sedative effect
has also been demonstrated [30]. The antinociceptive effect of α-bisabolol-rich EO has been
discovered to derive from downregulation of neuronal excitability and the inhibition of
inflammatory mediators and cytokines [55]. Target for bisabolol is probably the TRPA1
channel which plays a major role in the release of TNFα, which is one of the most important
inflammatory mediators in the human body. Studies also showed a higher IL-10 expression,
which is known for its anti-inflammatory effect [56]. Furthermore, the downregulation of
the FOS protein in the spinal cord through an EO-β cyclodextrin-complex proved to be a
promising treatment option for orofacial pain [55].
In another study, using the branches of the V. arbora tree for distillation and subse-
quent GC-MS analysis, a concentration of 91.02% α-bisabolol was determined. This main
compound, a sesquiterpene alcohol, plays an important role in the mode of action of EO.
Tests of EO and α-bisabolol on three different strains of C. albicans (CA INCQS 40006, CK
INCQS 40095, CT INCQS 40042) resulted in IC50 (µg/mL) values of 9.88, 23.89 and 584.9 for
EO and 8.92, 18.15 and 518.26, respectively. There were no significant differences between
the EO and the isolated compound. To test the behavior on bacterial strains, four antibiotics
(amikacin, gentamicin, ampicillin, and benzylpenicillin) were tested on two multidrug-
resistant pathogens (S. aureus 03 and E. coli 08) along with the entire EO and the isolated
α-bisabolol. In all tests, a synergistic effect was observed between the antibiotics and the
EO as well as the isolated α-bisabolol. This could open many doors in the treatment of
resistant bacterial strands. Combination with conventional antibiotics could result in lower
toxicity, lower minimum effective dose, and fewer side effects during antibiotic therapy.
Again, α-bisabolol is likely responsible for the antibiotic-modulating effect [26]. Further
studies on EO of V. arbora and α-bisabolol showed in toxicity against Leishmania amazonensis
in vitro. These investigations determined IC50 values of 7.35 µg/mL and 4.95 µg/mL of EO
and α-bisabolol against promastigotes and IC50 values of 12.58 µg/mL and 10.70 µg/mL
against intracellular amastigotes, respectively, without toxic activity against the treated
macrophages. The authors mentioned that the effect on the lipid metabolism of the para-
sites led to the accumulation of lipid precursors and caused morphological changes in the
cell membrane, resulting in the antileishmanial activity. This indicates further development
and future therapeutic use [27].
α-Bisabolol is commercially extracted from the EO of the tree and has been exten-
sively studied. In human and rat malignant glioma cells, it caused cell death by inducing
apoptosis. Cavalieri et al. described an involvement of the mitochondrial permeability
Molecules 2022, 27, 7295 12 of 17

transition. This is associated with the translocation of cytochrome C, suggesting that the
whole process triggers the intrinsic pathway of apoptosis. This process of cytotoxicity on
glioma cells has been shown to be time and dose dependent. However, the advantage of
this compound is at the same time its low toxic effect on animals, as shown in an animal
experiment with a rat administered 120 mg/kg α-bisabolol, which showed no toxic effects
after 24 h [57]. The low toxicity is also a reason why α-bisabolol is popular in cosmetics
and perfumes [27]. These results underscore the potential inherent in this compound. With
a CL50 of 15.9 mg/mL and CL90 of 28.5 mg/mL the EO of V. arborea further showed very
high larvicidal activity [58].

2.6. Cedrus deodara (Roxb. Ex. D. Don) G. Don (Pinaceae)

C. deodara is also known as “Himalayan cedar”. This tree is found on the slopes of the
Himalayas at an altitude of about 1650 to 2400 m above sea level. This includes regions
in northern and central India, northern Pakistan, western Nepal, eastern Afghanistan and
southwestern Tibet. The evergreen tree can reach a height of 65–85 m and a diameter of 4 m.
The bark of C. deodara is dark grayish-brown or reddish-brown in color and has diagonal
and vertical cracks [33,59]. The EO of the wood, as well as of the bark is used in medicine.
Antiseptic, insecticidal, antifungal, and anti-inflammatory are just some of the properties
attributed to the EO. It is also said to be applied against various animal diseases and as a
molluscicide. Commercially, the EO is an important ingredient for the perfume industry
and cosmetics, as well as in soap making [59]. Especially EOs of the Pinaceae family are
known for their antibacterial, larvicidal and antioxidant activities [60,61].
Reports of traditional Indian uses of C. deodara wood oil and bark powder include
application against colds, coughs, cancer, skin diseases, bronchitis, diarrhea, tuberculosis,
urination, itching, hemorrhoids, mental disorders, and blood diseases. In addition, the
vapors of the bark have been used as a snake repellent, but also against scabies and external
parasites. The bark and the wood are the most used parts of C. deodara [33].
A characterization of the yellow-colored EO of the bark identified by GC-MS described
monoterpenes (44.67%), sesquiterpenes (36.43%), and diterpenes (18.88%). The largest
proportions were listed as α-pinene (24.28%), cis-ocimene (14.11%; Figure 1k), longifolene
(8.28%; Figure 1l), cembrene (6.69%), α-copaene (6.56%), α-terpineol (3.73%), and verticellol
(3.03%) [31].
Subsequent tests against three fungal pathogens Curvularia lunata (IC50 value of
2.22 ± 0.13 µL/mL), Alternaria alternata (IC50 of 3.71 ± 0.12 µL/mL) and Bipolaris spicifer
(IC50 of 4.8 ± 0.34 µL/mL) showed antifungal activity, which is probably caused by the
high content of oxygenated monoterpenes in the EO of the bark. Further investigation
of the antifungal effect on C. lunata identified a mixture of ten different components as
the cause. This suggests that a synergistic effect seems to play an important role in the
mode of action. Molecular docking studies were performed that analyzed the binding
affinity of the antifungal fraction of C. deodara bark oil to the protein tri-hydro-naphthalene
reductase (ID-1YBV). Inhibition of pentaketidal melanin biosynthesis was determined to
be the antifungal mechanism of action. This makes the bark EO a potential candidate
fungicide against C. lunata [31]. α-Pinene, a major compound in the EO of the bark, showed
its antimicrobial properties against E. coli, S. aureus, Micrococcus luteus, and B. subtilis [32].
Analysis of the wood EO indicated more than 34 constituents. Mainly α-himachalene
(17.1%; Figure 1m) and β-himachalene (38.8%; Figure 1n) which are sesquiterpenehydro-
carbons with a hexahydrobenzocycloheptene basic skeleton and are not found in the bark
oil. Cedarwood oil with a high proportion of himachalenes is called “super rectified oil”
and with a high proportion of atlantones it is called “perfume quality” [61].
Other compounds found in wood EO by GC analysis were γ-himachalene (12.6%;
Figure 1o), (E)-α-atlantone (8.6%), cis-α-bisabolene (2.2%), (E)-γ-atlantone (2.4%), (Z)-γ-
atlantone (2.3%), and (Z)-α-atlantone (1.4%). With an overall identification of 98.3%, this
accounts for 79.5% sesquiterpene hydrocarbons and 18.9% oxygenated sesquiterpenes [61].
Molecules 2022, 27, 7295 13 of 17

In contrast, Tripathi et al. found atlantones and himachalene epoxides to be major con-
stituents in their study of cedarwood oil [62].
Several studies have demonstrated the analgesic and anti-inflammatory effects of
wood EO in chronic and acute stages. One main cause is the inhibition of the release of
inflammatory prostaglandins through the inhibition of cyclooxygenase enzymes. Other
studies also supported the membrane stabilizing effect of the oil. More research needs to
be done to investigate exactly which molecules cause the underlying mechanisms. In this
anti-inflammatory context, stabilization of mast cells was observed in rats, which could be
part of the anti-asthmatic mechanism. There are too few studies to fully explain this [33].
In addition, studies have looked at the insecticidal property. Fractions containing
himachalene as the main component showed particularly pronounced insecticidal proper-
ties against Musca domestica (house fly) and Callosobruchus chinensis (pulse beetle). Further
development of these components could provide a potent insecticide [33].
Finally, the toxicity of the wood oil was studied in mice. Animals receiving a dose
of 200–400 mg/kg showed signs of depression and mice receiving 500 mg/kg of the oil
showed 50% mortality [33]. Its traditional use as a remedy against gastric ulcers was
further investigated in another animal experiment on Wistar rats. C. deodara EO at a dose
of 100 mg/kg successfully reduced the number of ulcers, ulcer score and ulcer index. It
indicated inhibition of pyloric ligation induced gastric ulcers with 41.49%. Standard drug
rabeprazole, used as control in the investigation, inhibited 67.74% at 20 mg/kg. Ethanol-
induced ulcers showed inhibition of 50.17% at a dose of 100 mg/kg, while rabeprazole
20 mg/kg showed inhibition of 69.95% of ulcers. The exact mode of action remains to be
investigated [34]. Against K562 cancer cell lines, C. deodara wood oils revealed an IC50
of 37.79 µg/mL. According to other investigations, reviewed by Kumar and coworkers,
the active compounds causing the cytotoxic effect are believed to be α-pinene, β-pinene,
caryophyllene, and terpineol. β-Pinene showed antiproliferative properties against MCF-
7 breast cancer, A375 lung cancer and HepG2 liver cancer cells in various studies [32].
Recent studies on a virulence agent of SARS-CoV-2 investigated molecules containing the
backbone of α,β,γ-himachalenes from C. deodara. The goal was to find a potential inhibitor
of nonstructural protein 1 that restricts viral replication. The reason was that himachalene
scaffolds are known for their anti-inflammatory and antiviral properties [63].

3. Conclusions
This overview is intended to illustrate the different biological properties and chemical
composition of the various bark oils. Ultimately, however, it is also important to put the
commercial benefits into a realistic perspective. It must be clarified whether the plants can
be grown sustainably on plantations and thus used on a large scale. Soil conditions also
affect the essential oil, which will certainly present some challenges in the future. From a
European perspective, the bark oils seem to come from trees that are rather uncommon or
exotic. One reason for this could be that in Europe the trees are cut down producing EO
from wood and bark while in certain other areas of the world the outer bark is scraped
off and used independently from the wood. The centuries-long use of bark for clothing,
building materials, or simply as traditional medicine provided a great deal of traditional
knowledge. The easier accessibility of bark plays an important role. Due to the many
documented applications of bark oils [64], they will continue to gain importance in various
research areas in the future.
The antimicrobial properties of some bark oils mentioned, such as V. arborea, are
particularly noteworthy. The World Health Organization’s global report on surveillance
on antimicrobial resistance has highlighted that emerging resistance is a global threat.
The treatment of multidrug-resistant pathogens is a major challenge for medicine [65].
Reasons for this include the high use of antibiotics and inefficient or incorrect use. It is also
important to consider current world events. Approximately 15% of hospitalized COVID-19
patients develop secondary bacterial infections such as bacterial pneumonia or require
antibiotics for prophylaxis because they are on a ventilator [66]. This again highlights
Molecules 2022, 27, 7295 14 of 17

the need for alternatives and new solutions. One approach could be to focus on plants
with constituents that have antibiotic potential. EOs can influence the mode of action
of antibiotic substances. Studies have shown that the oil from the bark of V. arborea had
an enhancing effect when combined with various antibiotics. Exactly such synergistic
enhancing effects with antibiotics have also been observed with cinnamon oil and its
main constituent [67]. This supportive effect could be used in the future to circumvent
the resistance of multidrug-resistant pathogens and reduce the use of antibiotics. Thus,
they could also help to reduce the high incidence of ever-increasing antibiotic resistance.
Lowering the dose of antibiotics by combining them with an adjuvant such as EOs could
also reduce side effects by lowering the minimum effective dose of the drugs.
However, most of the studies discussed in this review were performed in vitro (Table 1)
and—although their results give a direction for future research—their outcome may not
be directly transferable to a clinical setup. Therefore, clinical studies as well as applied
investigations using EOs have to be performed and supported. Recently, for example,
Hawkins and coworkers determined the energy-level-increasing effect of various EOs
in women with post-COVID-19. In a randomized double bind trial, patients inhaled
blends of EOs for two weeks. Compared to the control group, fatigue level significantly
decreased (p = 0.02) [68]. In another study Lavandula angustifolia L. (Lamiaciae) EO showed
an antimicrobial effect especially against Staphylococcus when being dispensed over two
months in hospital environments [69]. A further investigation determined a significant
reduction of microbial contamination in a hospital by vaporizing a mixture of lemon and
fir EO. That way, concentrations of bacteria and fungi in the air was reduced by around
40% after two hours [70]. Nevertheless, in vivo studies further need to be conducted in the
future to provide a more accurate picture of the toxicity of certain antimicrobial bark EOs
on the human body and additionally their effect on the human microbiome. The routes of
administration also need to be clarified, as well as pharmacodynamic and pharmacokinetic
properties, which will certainly be a challenge for the future. More studies need to be done
to get a better understanding of the mechanism of action of bark EOs and their components.
Additionally, studies should focus on the efficacy and use of various bark oils, which have
not yet been extensively researched.

Author Contributions: Conceptualization, M.G. and I.S.; Writing—original draft preparation, M.G.;
Writing—review and editing, I.S.; Supervision, I.S. All authors have read and agreed to the published
version of the manuscript.
Funding: This research received no external funding.
Institutional Review Board Statement: Not applicable.
Informed Consent Statement: Not applicable.
Data Availability Statement: Not applicable.
Acknowledgments: The authors are thankful to Open Access Funding by the University of Vienna.
Conflicts of Interest: The authors declare no conflict of interest.
Sample Availability: Not applicable.

References
1. Sharifi-Rad, J.; Sureda, A.; Tenore, G.C.; Daglia, M.; Sharifi-Rad, M.; Valussi, M.; Tundis, R.; Sharifi-Rad, M.; Loizzo, M.R.;
Ademiluyi, A.O.; et al. Biological Activities of Essential Oils: From Plant Chemoecology to Traditional Healing Systems. Molecules
2017, 22, 70. [CrossRef]
2. Derbassi, N.B.; Pedrosa, M.C.; Heleno, S.; Carocho, M.; Ferreira, I.C.F.R.; Barros, L. Plant volatiles: Using scented molecules as
food additives. Trends Food. Sci. Technol. 2022, 122, 97–103. [CrossRef]
3. Falleh, H.; Jemaa, M.B.; Saada, M.; Ksouri, R. Essential oils: A promising eco-friendly food preservative. Food Chem. 2020,
330, 127268. [CrossRef]
4. Aelenei, P.; Miron, A.; Trifan, A.; Bujor, A.; Gille, E.; Aprotosoaie, A.C. Essential Oils and Their Components as Modulators of
Antibiotic Activity against Gram-Negative Bacteria. Medicines 2016, 3, 19. [CrossRef]
Molecules 2022, 27, 7295 15 of 17

5. Sarkic, A.; Stappen, I. Essential Oils and Their Single Compounds in Cosmetics—A Critical Review. Cosmetics 2018, 5, 11.
[CrossRef]
6. Fierascu, R.C.; Fierascu, I.C.; Dinu-Pirvu, C.E.; Fierascu, I.; Paunescu, A. The application of essential oils as a next-generation of
pesticides: Recent developments and future perspectives. Z. Naturforsch. C. J. Biosci. 2020, 75, 183–204. [CrossRef]
7. Hossein, N.; Zahra, Z.; Abolfazl, M.; Mahdi, S.; Ali, K. Effect of Cinnamon zeylanicum essence and distillate on the clotting time. J.
Med. Plant Res. 2013, 7, 1339–1343. [CrossRef]
8. Unlu, M.; Ergene, E.; Unlu, G.V.; Zeytinoglu, H.S.; Vural, N. Composition, antimicrobial activity and in vitro cytotoxicity of
essential oil from Cinnamomum zeylanicum Blume (Lauraceae). Food Chem. Toxicol. 2010, 48, 3274–3280. [CrossRef]
9. Kumar, S.; Kumari, R.; Mishra, S. Pharmacological properties and their medicinal uses of Cinnamomum: A review. J. Pharm.
Pharmacol. 2019, 71, 1735–1761. [CrossRef]
10. Tepe, A.S.; Ozaslan, M. Anti-alzheimer, anti-diabetic, skin-whitening, and antioxidant activities of the essential oil of Cinnamomum
zeylanicum. Ind. Crops Prod. 2020, 145, 112069. [CrossRef]
11. Jayaprakasha, G.K.; Rao, L.J.M. Chemistry, biogenesis, and biological activities of Cinnamomum zeylanicum. Crit. Rev. Food Sci.
Nutr. 2011, 51, 547–562. [CrossRef] [PubMed]
12. Ramazani, E.; YazdFazeli, M.; Emami, S.A.; Mohtashami, L.; Javadi, B.; Asili, J.; Tayarani-Najaran, Z. Protective effects of
Cinnamomum verum, Cinnamomum cassia and cinnamaldehyde against 6-OHDA-induced apoptosis in PC12 cells. Mol. Biol Rep.
2020, 47, 2437–2445. [CrossRef] [PubMed]
13. Han, X.; Parker, T.L. Antiinflammatory activity of Cinnamon (Cinnamomum zeylanicum) bark essential oil in a human skin disease
model. Phytother. Res. 2017, 31, 1034–1038. [CrossRef] [PubMed]
14. Tardugno, R.; Spagnoletti, A.; Grandini, A.; Maresca, I.; Sacchetti, G.; Pellati, F.; Benvenuti, S. Chemical profile and biological
activities of Cedrelopsis grevei H. Baillon bark essential oil. Plant Biosyst. 2018, 152, 120–129. [CrossRef]
15. Voundi, S.O.; Nyegue, M.; Lazar, I.; Raducanu, D.; Ndoye, F.F.; Marius, S.; Etoa, F.-X. Effect of essential oils on germination and
growth of some pathogenic and spoilage spore-forming bacteria. Foodborne Pathog. Dis. 2015, 12, 551–559. [CrossRef]
16. Olugu, S.V.; Nyegue, M.A.; Lazar, I.; Stamate, M.; Raducanu, D.; Rati, I.V.; Etoa, F.-X. Effect of Drypetes gossweileri essential oil
and irradiation treatments on inhibition and sensitivity of bacterial spores. Food Sci. Technol. Int. 2020, 26, 65–77. [CrossRef]
17. Moni, N.E.D.F.; Nyegue, M.A.; Assam Assam, J.P.; Betote, D.P.H.; Feudjieu, E.G.; Penlap, B.V.; Etoa, F.-X. Effects of essential oil
from Drypetes gossweileri S. Moore stem barks on cell release and dna synthesis of Mycobacterium tuberculosis. J. Drug Deliv.
Ther. 2019, 9, 319–324. [CrossRef]
18. Ndoye Foe, F.M.-C.; Tchinang, T.F.K.; Nyegue, A.M.; Abdou, J.-P.; Yaya, A.J.G.; Tchinda, A.T.; Essame, J.-L.O.; Etoa, F.-X. Chemical
composition, in vitro antioxidant and anti-inflammatory properties of essential oils of four dietary and medicinal plants from
Cameroon. BMC Complement. Altern. Med. 2016, 16, 117. [CrossRef]
19. Pratiwi, S.U.T.; Hertiani, T. Efficacy of massoia oil in combination with some indonesian medical plants oils as anti-biofilm agent
towards candida albicans. Int. J. Pharm. Sci. 2017, 8, 2013–2025. [CrossRef]
20. Permanasari, P.; Hertiani, T.; Yuswanto, A. In vitro evaluation of massoia bark essential oil and C-10 massoialactone potency as
immunomodulator. J. Essent. Oil-Bear. Plants 2017, 20, 459–467. [CrossRef]
21. Rolli, E.; Marieschi, M.; Maietti, S.; Guerrini, A.; Grandini, A.; Sacchetti, G.; Bruni, R. Phytotoxic effects and phytochemical
fingerprinting of hydrodistilled oil, enriched fractions, and isolated compounds obtained from Cryptocarya massoy (Oken) Kosterm.
Bark. Chem. Biodivers. 2016, 13, 66–76. [CrossRef]
22. Barros, M.E.S.B.; Freitas, J.C.R.; Oliveira, J.M.; da Cruz, C.H.B.; da Silva, P.B.N.; de Araújo, L.C.C.; Militão, G.C.G.; da Silva, T.G.;
Oliveira, R.A.; Menezes, P.H. Synthesis and evaluation of (-)-massoialactone and analogues as potential anticancer and anti-
inflammatory agents. Eur. J. Med. Chem. 2014, 76, 291–300. [CrossRef]
23. Batubara, I.; Hadi Prayogo, Y.; Suparto, I.H.; Juliandi, B.; Uchiyama, S. Inhalation effect of massoilactone from massoia essential
oil on lipid profile, liver tissues, and body weight of Sprague Dawley rat. J. Appl. Pharm. Sci. 2019, 9, 111–116. [CrossRef]
24. Teixeira, A.M.R.; Lima, I.K.C.; Xavier, M.R.; Pereira, R.L.S.; Gonçalves, B.G.; de Sena, D.M.; da Costa, J.M.; Freire, P.T.C.;
Saraiva, G.D.; Bento, R.R.F.; et al. Vibrational spectroscopy study of essential oils from Plectranthus amboinicus Lour. Spreng and
Vanillosmopsis arborea Baker. Vib. Spectrosc. 2018, 98, 22–29. [CrossRef]
25. Santos, N.K.A.; Rodrigues, F.F.G.; Coutinho, H.D.; Viana, G.S.B.; Costa, J.G.M. Isolation of alpha-bisabolol from the essential
oil of Vanillosmopsis arborea Baker and modulation of antibiotic activity using gaseous contact. J. Essent. Oil-Bear. Plants 2013,
16, 826–831. [CrossRef]
26. Rodrigues, F.F.G.; Colares, A.V.; Nonato, C.D.F.A.; Galvão-Rodrigues, F.F.; Mota, M.L.; Moraes Braga, M.F.B.; de Fatima Alves
Nonato, C.J.G.M. In vitro antimicrobial activity of the essential oil from Vanillosmopsis arborea Barker (Asteraceae) and its major
constituent, α-bisabolol. Microb. Pathog. 2018, 125, 144–149. [CrossRef]
27. Colares, A.V.; Almeida-Souza, F.; Taniwaki, N.N.; Souza, C.D.S.F.; da Costa, J.G.M.; Calabrese, K.D.S.; Abreu-Silva, A.L. In Vitro
antileishmanial activity of essential oil of Vanillosmopsis arborea (Asteraceae) Baker. Evid. Based Compl. Alt. Med. 2013, 2013, 727042.
[CrossRef]
28. de Leite, G.O.; da Penha, A.R.; Fernandes, C.N.; Souza, H.H.F.; da Costa, J.G.M.; Campos, A.R. Gastroprotective mechanism of
Vanillosmopsis arborea bark essential oil. Fitoterapia 2009, 80, 77–80. [CrossRef]
29. Leite, L.I.; Leite, G.D.O.; Silva, B.A.F.; Sousa, S.D.G.; Coutinho, T.S.; Sampaio, R.S.; Menezes, I.; Costa, J.G.M.; Campos, A.R.
Antinociceptive action of Vanillosmopsis arborea in male mice. Avicenna J. Phytomedicine 2017, 7, 92–98.
Molecules 2022, 27, 7295 16 of 17

30. da Costa, J.G.; Santos, N.K.; Viana, G.S.; Cunha, W.; Campos, A. The essential oil from Vanillosmopsis arborea Baker (Asteraceae)
presents antinociceptive, anti-inflammatory, and sedative effects. Int. J. Green Pharm. 2015, 9, 138. [CrossRef]
31. Kumar, A.; Suravajhala, R.; Bhagat, M. Bioactive potential of Cedrus deodara (Roxb.) Loud essential oil (bark) against Curvularia
lunata and molecular docking studies. SN Appl. Sci. 2020, 2, 1045. [CrossRef]
32. Saab, A.M.; Gambari, R.; Sacchetti, G.; Guerrini, A.; Lampronti, I.; Tacchini, M.; El Samrani, A.; Medawar, S.; Makhlouf, H.;
Tannoury, M.; et al. Phytochemical and pharmacological properties of essential oils from Cedrus species. Nat. Prod. Res. 2018,
32, 1415–1427. [CrossRef]
33. Bisht, A.; Jain, S.; Misra, A.; Dwivedi, J.; Paliwal, S.; Sharma, S. Cedrus deodara (Roxb. ex D.Don) G.Don: A review of traditional
use, phytochemical composition and pharmacology. J. Ethnopharmacol. 2021, 279, 114361. [CrossRef]
34. Kumar, A.; Singh, V.; Chaudhary, A.K. Gastric antisecretory and antiulcer activities of Cedrus deodara (Roxb.) Loud. in Wistar rats.
J. Ethnopharmacol. 2011, 134, 294–297. [CrossRef]
35. Barceloux, D.G. Cinnamon (Cinnamomum species). Dis. Mon. 2009, 55, 327–335. [CrossRef]
36. Azad, R.; Kumara, K.W.; Senanayake, G.; Ranawaka, R.A.A.K.; Pushpakumara, D.K.N.G.; Geekiyanage, S. Flower morphological
diversity of cinnamon (Cinnamomum verum Presl) in Matara District, Sri Lanka. Open Agric. 2018, 3, 236–244. [CrossRef]
37. Rao, P.V.; Gan, S.H. Cinnamon: A multifaceted medicinal plant. Evid. Based Complement. Altern. Med. 2014, 2014, 642942.
[CrossRef] [PubMed]
38. Wang, J.; Su, B.; Jiang, H.; Cui, N.; Yu, Z.; Yang, Y.; Sun, Y. Traditional uses, phytochemistry and pharmacological activities of the
genus Cinnamomum (Lauraceae): A review. Fitoterapia 2020, 146, 104675. [CrossRef]
39. Gould, M.N.; Moore, C.J.; Zhang, R.; Wang, B.; Kennan, W.S.; Haag, J.D. Limonene chemoprevention of mammary carcinoma
induction following direct in situ transfer of v-Ha-ras. Cancer Res. 1994, 54, 2540–3543.
40. Randrianarivony, T.N.; Ramarosandratana, A.V.; Andriamihajarivo, T.H.; Rakotoarivony, F.; Jeannoda, V.H.; Randrianasolo,
A.; Bussmann, R.W. The most used medicinal plants by communities in Mahaboboka, Amboronabo, Mikoboka, Southwestern
Madagascar. J. Ethnobiol. Ethnomed. 2017, 13, 19. [CrossRef]
41. Rakotobea, M.; Menutb, C.; Andrianoelisoac, H.S.; Rahajanirinaa, V.; Collas de Chatelperrond, P.; Rogera, E.; Danthud, P. The bark
essential oil composition and chemotaxonomical appraisal of Cedrelopsis grevei H. Baillon from Madagascar. Nat. Prod. Commun.
2008, 3, 1145–1150. [CrossRef]
42. Gauvin, A.; Ravaomanarivo, H.; Smadja, J. Comparative analysis by gas chromatography-mass spectrometry of the essential
oils from bark and leaves of Cedrelopsis grevei Baill, an aromatic and medicinal plant from Madagascar. J. Chromatogr. A. 2004,
1029, 279–282. [CrossRef] [PubMed]
43. Cavalli, J.-F.; Tomi, F.; Bernardini, A.-F.; Casanova, J. Composition and chemical variability of the bark oil of Cedrelopsis grevei H.
Baillon from Madagascar. Flav. Frag. J. 2003, 18, 532–538. [CrossRef]
44. Mesa, C.L.; Ranalison, O.; Randriantseheno, L.N.; Risuleo, G. Natural Products from Madagascar, Socio-Cultural Usage, and
Potential Applications in Advanced Biomedicine: A Concise Review. Molecules 2021, 26, 4507. [CrossRef]
45. Um, B.H.; Lobstein, A.; Weniger, B.; Spiegel, C.; Yice, F.; Rakotoarison, O.; Andriantsitohaina, R.; Anton, R. New coumarins from
Cedrelopsis grevei. Fitoterapia 2003, 74, 638–642. [CrossRef]
46. Wansi, J.D.; Wandji, J.; Sewald, N.; Nahar, L.; Martin, C.; Sarker, S.D. Phytochemistry and pharmacology of the genus Drypetes: A
review. J. Ethnopharmacol. 2016, 190, 328–353. [CrossRef]
47. Agnaniet, H.; Mounzeo, H.; Menut, C.; Bessiere, J.-M.; Criton, M. The essential oils of Rinorea subintegrifolia O. Ktze and
Drypetes gossweileri S. Moore occurring in Gabon. Flavour Fragr. J. 2003, 18, 207–210. [CrossRef]
48. Mvé-Mba, C.E.; Menut, C.; Bessière, J.M.; Lamaty, G.; Ekekang, L.N.; Denamganai, J. Aromatic plants of tropical Central Africa.
XXIX. Benzyl Isothiocyanate as major constituent of bark essential oil of Drypetes gossweileri S. Moore. J. Essent. Oil Res. 1997,
9, 367–370. [CrossRef]
49. Scherer, R.; Godoy, H.T. Antioxidant activity index (AAI) by the 2,2-diphenyl-1-picrylhydrazyl method. Food Chem. 2009,
112, 654–658. [CrossRef]
50. Bosoren, M.B. Overview: Massoi: Cryptocarya massoia (Oken) Kosterm; GIZ, FORCLIME: Jakarta, Indonesia, 2020.
51. Urbain, A.; Corbeiller, P.; Aligiannis, N.; Halabalaki, M.; Skaltsounis, A.-L. Hydrostatic countercurrent chromatography and ultra
high pressure LC: Two fast complementary separation methods for the preparative isolation and the analysis of the fragrant
massoia lactones. J. Sep. Sci. 2010, 33, 1198–1203. [CrossRef]
52. Timotius, K.H.; Sari, I.N.; Santoso, A.W. Major bioactive compounds of pilis plant materials: A GC-MS analysis. Phcog. Commn.
2015, 5, 190–196. [CrossRef]
53. Rali, T.; Wossa, S.W.; Leach, D.N. Comparative chemical analysis of the essential oil constituents in the bark, heartwood and fruits
of Cryptocarya massoy (Oken) Kosterm. (Lauraceae) from Papua New Guinea. Molecules 2007, 12, 149–154. [CrossRef] [PubMed]
54. Yeny, I.; Darwo, H.S.N. Sustainability of masoyi (Cryptocarya Massoy (Oken) Kosterm) for essential oil industry materials. IOP
Conf. Ser. Mater. Sci. Eng. 2020, 935, 12071. [CrossRef]
55. Leite, L.H.I.; Leite, G.O.; da Silva, B.A.F.; Santos, S.A.A.R.; Magalhães, F.E.A.; Menezes, P.P.; Serafini, M.R.; Teixeira, C.S.;
Brito, R.G.; Santos, P.L.; et al. Molecular mechanism underlying orofacial antinociceptive activity of Vanillosmopsis arborea Baker
(Asteraceae) essential oil complexed with β-cyclodextrin. Phytomedicine 2019, 55, 293–301. [CrossRef]
Molecules 2022, 27, 7295 17 of 17

56. Fontinele, L.L.; Heimfarth, L.; Pereira, E.W.M.; Rezende, M.M.; Lima, N.T.; Carvalho, Y.M.B.G.D.; Pires, E.A.D.M.P.;
Guimarães, A.G.; Carvalho, M.T.B.; Barreto, R.D.S.S.; et al. Anti-hyperalgesic effect of (-)-α-bisabolol and (-)-α-bisabolol/β-
Cyclodextrin complex in a chronic inflammatory pain model is associated with reduced reactive gliosis and cytokine modulation.
Neurochem. Int. 2019, 131, 104530. [CrossRef] [PubMed]
57. Cavalieri, E.; Mariotto, S.; Fabrizi, C.; de Prati, A.C.; Gottardo, R.; Leone, S.; Berra, L.V.; Lauro, G.M.; Ciampa, A.R.; Suzuki, H.
α-Bisabolol, a nontoxic natural compound, strongly induces apoptosis in glioma cells. Biochem. Biophys. Res. Commun. 2004,
315, 589–594. [CrossRef] [PubMed]
58. Kamatou, G.P.P.; Viljoen, A.M. A review of the application and pharmacological properties of α-bisabolol and α-bisabolol-rich
oils. J. Am. Oil Chem. Soc. 2010, 87, 1–7. [CrossRef]
59. Kumar, S.; Kumar, A.; Kumar, R. Himalayan (Himachal region) cedar wood (Cedrus deodara: Pinaceae) essential oil, its processing,
ingredients and uses: A review. J. Pharmacogn. Phytochem. 2019, 8, 2228–2238.
60. Huang, K.; Liu, R.; Zhang, Y.; Guan, X. Characteristics of two cedarwood essential oil emulsions and their antioxidant and
antibacterial activities. Food Chem. 2021, 346, 128970. [CrossRef]
61. Chaudhary, A.; Kaur, P.; Singh, B.; Pathania, V. Chemical composition of hydrodistilled and solvent volatiles extracted from
woodchips of himalayan cedrus: Cedrus deodara (Roxb.) Loud. Nat. Prod. Commun. 2009, 4, 1257–1260. [CrossRef]
62. Tripathi, S.; Kumar, P.; Rout, K.P.; Khare, S.K.; Naik, S. An innovative approach for the detection of high boiler adulterants in
Sandalwood and Cedarwood essential oils. J. Sci. Ind. Res. 2021, 80, 866–874.
63. Singh, R.; Bhardwaj, V.K.; Das, P.; Purohit, R. A computational approach for rational discovery of inhibitors for non-structural
protein 1 of SARS-CoV-2. Comput. Biol. Med. 2021, 135, 104555. [CrossRef] [PubMed]
64. Pásztory, Z.; Mohácsiné, I.R.; Gorbacheva, G.; Börcsök, Z. The utilization of tree bark. BioRes 2016, 11, 7859–7888. [CrossRef]
65. World Health Organization. Antimicrobial Resistance: Global Report on Surveillance; WHO: Geneva, Switzerland, 2014.
66. McKenna, M. The antibiotic gamble. Nature 2020, 584, 338–341. [CrossRef] [PubMed]
67. El Atki, Y.; Aouam, I.; El Kamari, F.; Taroq, A.; Nayme, K.; Timinouni, M.; Lyoussi, B.; Abdellaoui, A. Antibacterial activity of
cinnamon essential oils and their synergistic potential with antibiotics. J. Adv. Pharm. Technol. 2019, 10, 63–67. [CrossRef]
68. Hawkins, J.; Hires, C.; Keenan, L.; Dunne, E. Aromatherapy blend of thyme, orange, clove bud, and frankincense boosts energy
levels in post-COVID-19 female patients: A randomized, double-blinded, placebo controlled clinical trial. Compl. Therap. Med.
2022, 67, 102823. [CrossRef]
69. Gismondi, A.; Marco, G.D.; Redi, E.L.; Ferrucci, L.; Cantonetti, M.; Canini, A. The antimicrobial activity of Lavandula angustifolia
Mill. essential oil against Staphylococcus species in a hospital environment. J. Herb. Med. 2021, 26, 100426. [CrossRef]
70. Lanzerstorfer, A.; Hackl, M.; Schlömer, M.; Rest, B.; Deutsch-Frasl, E.; Lanserstorfer, C. The influence of air-dispersed essentiaal
oils from lemon (Citrus limon) and silver fir (Abies alba) on airborne bacteria and fungi in hospital rooms. J. Environm. Sci. Health A
2019, 54, 256–260. [CrossRef]